✦ LIBER ✦

A new trial of the efficacy, tolerability, and safety of angiotensin-converting enzyme inhibition in mild systemic hypertension with concomitant diseases and therapies

✍ Scribed by Klaus O. Stumpe; A. Overlack

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Angiotensin-converting enzyme inhibition

✍ Klaus O. Stumpe; Axel Overlack 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 433 KB

Long-term efficacy of angiotensin-conver

✍ KO Stumpe; A Overlack; R Kolloch; S Schreyer 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 844 KB

Valsartan, a new angiotensin II antagoni

✍ Black, H R; Graff, A; Shute, D; Stoltz, R; Ruff, D; Levine, J; Shi, Y; Mallows, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 272 KB

Efficacy, tolerance and hormonal effects

✍ Bengt E. Karlberg; Torbjörn Lindström; Ulf Rosenqvist; K.Peter Öhman 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 682 KB

A comparison of the efficacy and tolerab

✍ B.E. Karlberg; U. Rosenqvist; T. Lindström; A.-M. Ottosson; P.-O. Andersson; J. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Efficacy of combination therapy with a c

✍ Tadashi Nakanishi; Masato Nishimura; Hakuo Takahashi; Manabu Yoshimura 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 498 KB